The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,012.00
Bid: 2,000.00
Ask: 2,004.00
Change: 18.00 (0.90%)
Spread: 4.00 (0.20%)
Open: 1,991.00
High: 2,012.00
Low: 1,969.00
Prev. Close: 1,994.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Nov 2022 09:50

RNS Number : 7698G
Hikma Pharmaceuticals Plc
17 November 2022
 

TR-1: Standard form for notification of major holdings

 

 LONDON, 17 November 2022 - Hikma Pharmaceuticals PLC (LEI:549300BNS685UXH4JI75) (LSE: HIK) (NasdaqDubai: HIK) announces as follows:

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Hikma Pharmaceuticals PLC

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

BlackRock, Inc.

City and country of registered office (if applicable)

Wilmington, DE, USA

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

15/11/2022

6. Date on which issuer notified (DD/MM/YYYY):

16/11/2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.910000

0.670000

5.580000

12314390

Position of previous notification (if

applicable)

5.090000

0.590000

5.680000

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

GB00B0LCW083

10822073

4.910000

SUBTOTAL 8. A

10822073  

4.910000%  

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

Securities Lending

1328470

0.600000

SUBTOTAL 8. B 1

1328470

0.600000%

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

CFD

Cash

163847

0.070000

 

SUBTOTAL 8.B.2

163847

0.070000%

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

See Schedule 9, below

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

BlackRock Regulatory Threshold Reporting Team

Jana Blumenstein

020 7743 3650

 

 

Place of completion

12 Throgmorton Avenue, London, EC2N 2DL, U.K.

Date of completion

16 November 2022

 

 

Schedule - Section 9

 

 

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

BlackRock, Inc. (Chain 1)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 1)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 1)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 1)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 1)

BlackRock (Singapore) Holdco Pte. Ltd.

BlackRock, Inc. (Chain 1)

BlackRock HK Holdco Limited

BlackRock, Inc. (Chain 1)

BlackRock Lux Finco S.a.r.l.

BlackRock, Inc. (Chain 1)

BlackRock Japan Holdings GK

BlackRock, Inc. (Chain 1)

BlackRock Japan Co., Ltd.

BlackRock, Inc. (Chain 2)

Trident Merger, LLC

BlackRock, Inc. (Chain 2)

BlackRock Investment Management, LLC

BlackRock, Inc. (Chain 3)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 3)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 3)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 3)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 3)

BlackRock Holdco 3, LLC

BlackRock, Inc. (Chain 3)

BlackRock Cayman 1 LP

BlackRock, Inc. (Chain 3)

BlackRock Cayman West Bay Finco Limited

BlackRock, Inc. (Chain 3)

BlackRock Cayman West Bay IV Limited

BlackRock, Inc. (Chain 3)

BlackRock Group Limited

BlackRock, Inc. (Chain 3)

BlackRock Finance Europe Limited

BlackRock, Inc. (Chain 3)

BlackRock Investment Management (UK) Limited

BlackRock, Inc. (Chain 4)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 4)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 4)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 4)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 4)

BlackRock Australia Holdco Pty. Ltd.

BlackRock, Inc. (Chain 4)

BlackRock Investment Management (Australia) Limited

BlackRock, Inc. (Chain 5)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 5)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 5)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 5)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 5)

BlackRock Holdco 3, LLC

BlackRock, Inc. (Chain 5)

BlackRock Cayman 1 LP

BlackRock, Inc. (Chain 5)

BlackRock Cayman West Bay Finco Limited

BlackRock, Inc. (Chain 5)

BlackRock Cayman West Bay IV Limited

BlackRock, Inc. (Chain 5)

BlackRock Group Limited

BlackRock, Inc. (Chain 5)

BlackRock International Limited

BlackRock, Inc. (Chain 6)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 6)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 6)

BlackRock Holdco 4, LLC

BlackRock, Inc. (Chain 6)

BlackRock Holdco 6, LLC

BlackRock, Inc. (Chain 6)

BlackRock Delaware Holdings Inc.

BlackRock, Inc. (Chain 6)

BlackRock Institutional Trust Company, National Association

BlackRock, Inc. (Chain 7)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 7)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 7)

BlackRock Holdco 4, LLC

BlackRock, Inc. (Chain 7)

BlackRock Holdco 6, LLC

BlackRock, Inc. (Chain 7)

BlackRock Delaware Holdings Inc.

BlackRock, Inc. (Chain 7)

BlackRock Fund Advisors

BlackRock, Inc. (Chain 8)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 8)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 9)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 9)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 9)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 9)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 9)

BlackRock (Singapore) Holdco Pte. Ltd.

BlackRock, Inc. (Chain 9)

BlackRock HK Holdco Limited

BlackRock, Inc. (Chain 9)

BlackRock Asset Management North Asia Limited

BlackRock, Inc. (Chain 10)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 10)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 10)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 10)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 10)

BlackRock Holdco 3, LLC

BlackRock, Inc. (Chain 10)

BlackRock Cayman 1 LP

BlackRock, Inc. (Chain 10)

BlackRock Cayman West Bay Finco Limited

BlackRock, Inc. (Chain 10)

BlackRock Cayman West Bay IV Limited

BlackRock, Inc. (Chain 10)

BlackRock Group Limited

BlackRock, Inc. (Chain 10)

BlackRock Finance Europe Limited

BlackRock, Inc. (Chain 10)

BlackRock (Netherlands) B.V.

BlackRock, Inc. (Chain 10)

BlackRock Asset Management Deutschland AG

BlackRock, Inc. (Chain 11)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 11)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 11)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 11)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 11)

BlackRock Holdco 3, LLC

BlackRock, Inc. (Chain 11)

BlackRock Canada Holdings LP

BlackRock, Inc. (Chain 11)

BlackRock Canada Holdings ULC

BlackRock, Inc. (Chain 11)

BlackRock Asset Management Canada Limited

BlackRock, Inc. (Chain 12)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 12)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 12)

BlackRock Capital Holdings, Inc.

BlackRock, Inc. (Chain 12)

BlackRock Advisors, LLC

BlackRock, Inc. (Chain 13)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 13)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 13)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 13)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 13)

BlackRock Holdco 3, LLC

BlackRock, Inc. (Chain 13)

BlackRock Cayman 1 LP

BlackRock, Inc. (Chain 13)

BlackRock Cayman West Bay Finco Limited

BlackRock, Inc. (Chain 13)

BlackRock Cayman West Bay IV Limited

BlackRock, Inc. (Chain 13)

BlackRock Group Limited

BlackRock, Inc. (Chain 13)

BlackRock Finance Europe Limited

BlackRock, Inc. (Chain 13)

BlackRock Advisors (UK) Limited

BlackRock, Inc. (Chain 14)

BlackRock Holdco 2, Inc.

BlackRock, Inc. (Chain 14)

BlackRock Financial Management, Inc.

BlackRock, Inc. (Chain 14)

BlackRock International Holdings, Inc.

BlackRock, Inc. (Chain 14)

BR Jersey International Holdings L.P.

BlackRock, Inc. (Chain 14)

BlackRock (Singapore) Holdco Pte. Ltd.

BlackRock, Inc. (Chain 14)

BlackRock (Singapore) Limited

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLUBSKRUBUAARA
Date   Source Headline
5th Oct 20179:49 amRNSBlock listing Interim Review
2nd Oct 20173:36 pmRNSTotal Voting Rights
28th Sep 20173:29 pmRNSHolding(s) in Company
25th Sep 201711:27 amRNSHolding(s) in Company
14th Sep 20173:52 pmRNSHolding(s) in Company
25th Aug 20178:41 amRNSHolding(s) in Company
17th Aug 20177:00 amRNSHikma announces licensing agreement with Takeda
17th Aug 20177:00 amRNSHalf-year Report
10th Aug 201710:05 amRNSDirector/PDMR Shareholding
10th Aug 201710:02 amRNSDirector/PDMR Shareholding
9th Aug 20179:54 amRNSDirector/PDMR Shareholding
4th Aug 20179:56 amRNSHolding(s) in Company
3rd Aug 20172:22 pmRNSNotice of Results
24th Jul 201710:53 amRNSHolding(s) in Company
4th Jul 201711:02 amRNSTotal Voting Rights
3rd Jul 20173:03 pmRNSHolding(s) in Company
30th Jun 20174:11 pmRNSHolding(s) in Company
26th Jun 20177:00 amRNSLeadership and Structural Changes to US Business
12th Jun 20174:31 pmRNSDirector/PDMR Shareholding
2nd Jun 20174:51 pmRNSTotal Voting Rights
31st May 20179:38 amRNSDirector/PDMR Shareholding
19th May 20172:44 pmRNSResult of AGM
19th May 20177:00 amRNSTrading Statement
15th May 20173:30 pmRNSDirector/PDMR Shareholding
11th May 20177:50 amRNSHikma update on ANDA for generic Advair Diskus
8th May 20179:23 amRNSChange of Registered Address
3rd May 20175:23 pmRNSTotal Voting Rights
3rd May 201710:37 amRNSChange of Registered Office
28th Apr 20172:30 pmRNSDirector/PDMR Shareholding
28th Apr 20171:57 pmRNSDirector/PDMR Shareholding
24th Apr 20173:35 pmRNSDirector/PDMR Shareholding
13th Apr 20178:58 amRNSDirector/PDMR Shareholding
13th Apr 20178:43 amRNSDirector/PDMR Shareholding
13th Apr 20178:42 amRNSDirector/PDMR Shareholding
13th Apr 20178:41 amRNSDirector/PDMR Shareholding
13th Apr 20178:36 amRNSDirector/PDMR Shareholding
11th Apr 20174:01 pmRNSDirector/PDMR Shareholding
7th Apr 201711:55 amRNSAnnual Financial Report
6th Apr 20177:00 amRNSHikma enters into settlement agreement with Jazz
3rd Apr 20173:59 pmRNSTotal Voting Rights
3rd Apr 20173:56 pmRNSBlock listing Interim Review
27th Mar 201711:13 amRNSHolding(s) in Company
23rd Mar 20179:30 amRNSDirector/PDMR Shareholding
15th Mar 20177:00 amRNSFinal Results
10th Mar 20177:30 amRNSHikma launches Desvenlafaxine Succinate Tablets
8th Mar 20174:01 pmRNSNotice of Results
8th Mar 20171:30 pmRNSDirector/PDMR Shareholding
1st Mar 20172:38 pmRNSTotal Voting Rights
13th Feb 20179:19 amRNSLicensing agreement with Orion for Easyhaler®
6th Feb 20172:27 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.